CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-08 | MENDLEIN JOHN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-12-21 | MENDLEIN JOHN Director | Purchase | +195,000 | $0.42 | $83K | 615,382 |
| 2018-12-20 | MENDLEIN JOHN Director | Purchase | +50,000 | $0.41 | $21K | 420,382 |
| 2018-05-15 | MENDLEIN JOHN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-01-02 | MENDLEIN JOHN Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2017-08-31 | MENDLEIN JOHN CEO and Director | Purchase | +37,736 | $2.65 | $100K | 367,883 |
| 2017-08-31 | MENDLEIN JOHN CEO and Director | Purchase · Warrant to Purchase Common Stock | +14,151 | 14,151 | ||
| 2017-04-24 | MENDLEIN JOHN CEO and Director | Purchase | +124 | $3.00 | $372 | 327,647 |
| 2017-04-20 | MENDLEIN JOHN CEO and Director | Purchase | +1,552 | $3.00 | $5K | 327,523 |
| 2017-04-18 | MENDLEIN JOHN CEO and Director | Purchase | +1,000 | $3.00 | $3K | 325,971 |
| 2017-02-07 | MENDLEIN JOHN CEO and Director | Grant or award · Employee Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2016-12-19 | MENDLEIN JOHN CEO and Director | Purchase | +69,000 | $2.20 | $152K | 324,971 |
| 2016-04-05 | MENDLEIN JOHN CEO and Director | Purchase | +2,500 | $3.52 | $9K | 250,971 |
| 2016-04-05 | MENDLEIN JOHN CEO and Director | Purchase | +2,500 | $3.55 | $9K | 248,471 |
| 2016-01-27 | MENDLEIN JOHN CEO and Director | Grant or award · Employee Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2016-01-04 | MENDLEIN JOHN CEO and Director | Grant or award · Employee Stock Option (right to buy) | +148,732 | 148,732 | ||
| 2015-10-01 | MENDLEIN JOHN See Remarks | Grant or award · Employee Stock Option (right to buy) | +71,000 | 71,000 | ||
| 2015-10-01 | MENDLEIN JOHN See Remarks | Grant or award · Employee Stock Option (right to buy) | +65,070 | 65,070 | ||
| 2015-05-12 | MENDLEIN JOHN CEO and Executive Chairman | Conversion | +24,055 | 245,971 | ||
| 2015-05-12 | MENDLEIN JOHN CEO and Executive Chairman | Conversion · Series C Redeemable Convertible Preferred Stock | −170,218 | 0 |
Page 1 of 2 · 22 trades